The Anti-Red Tape Authority (ARTA) welcomes the move of the Food and Drug Administration (FDA) for granting the application of a hospital for a Compassionate Special Permit to use Ivermectin on humans with COVID-19. With this, ARTA urges FDA to continue processing applications from other medical institutions seeking the same permit expeditiously while key agencies.. read more
ARTA to discuss with DOH, FDA the inclusion of Ivermectin in the COVID-19 treatment protocol for emergency use
30 March 2021 – The Anti-Red Tape Authority (ARTA) will discuss the possible inclusion of Ivermectin in the COVID-19 treatment protocol with the Department of Health (DOH) and the Food and Drug Administration (FDA) on its meeting with the said agencies tomorrow, Wednesday. This, after FDA Director General Eric Domingo explained in a meeting earlier.. read more
ARTA to FDA: Expedite application process for Ivermectin
29 March 2021 – The Anti-Red Tape Authority (ARTA) is urging the Food and Drug Administration (FDA) to expedite its processing of applications for the use of Ivermectin, an anti-parasitic drug undergoing trials for the possible treatment of COVID-19 symptoms. This, after the FDA announced earlier today that doctors and hospitals may now apply for.. read more
ARTA declares pending applications automatically renewed from FDA list of 2,250
11 February 2021 – The Anti-Red Tape Authority (ARTA) is issuing a Declaration of Completeness and Order of Automatic Renewal to the Center for Drug Regulation and Research (CDRR) of the Food and Drug Administration (FDA) for 2,250 low risk to no risk Automatic Renewal Applications of Certificate of Product Registration (CPR) which were left.. read more
ARTA conducts surprise inspections at gov’t offices following reports of long queues
20 January 2021 – Apart from its ongoing inspections of the Business One-Stop Shops of LGUs, the Anti-Red Tape Authority (ARTA) also conducted surprise visits at the Social Security System branch at SM Aura last week and at the Professional Regulation Commission – Morayta and Food and Drug Administration this week. ARTA conducted the surprise.. read more